PLYX · Polaryx Therapeutics, Inc.

Substantial doubt about the company's ability to continue as a going concern.

“These matters, along with the conditions described above, raise substantial doubt about the Company's ability to continue as a going concern for a period of twelve months from the date these financial statements were available to be issued.”